A utility-based model for comparing the cost-effectiveness of diagnostic studies.

Area of Science:

• Medical Decision Making
• Health Economics
• Diagnostic Test Evaluation

Background:

• The cost-effectiveness of diagnostic tests is crucial for healthcare resource allocation.
• Current models often focus solely on direct costs, neglecting test performance and clinical utility.
• Diagnostic test performance is influenced by observer interactions within a clinical setting.

Purpose of the Study:

• To introduce a novel model for evaluating diagnostic tests based on effective cost.
• To incorporate diagnostic utility and clinical decision analysis into cost-effectiveness calculations.
• To provide a more clinically realistic framework for comparing diagnostic tests.

Main Methods:

• Defined effective cost (EC) as actual direct cost (ADC) divided by diagnostic utility (DU).
• Diagnostic utility (DU) was calculated as the probability-weighted sum of utilities for true positive, true negative, false positive, and false negative outcomes.
• Incorporated sensitivity (Se), specificity (Sp), equivocal fraction (EF), disease probability (P(D)), and outcome utility (U) into the DU calculation.

Main Results:

• Effective cost equals actual direct cost for a perfect test (DU=1).
• Effective cost exceeds actual direct cost when diagnostic utility is less than 1.
• The effective cost of a test is highly dependent on the pre-test probability of disease (P(D)) when sensitivity and specificity differ significantly.

Conclusions:

• The effective cost model offers a more clinically realistic evaluation of diagnostic tests by integrating performance and utility.
• This model accounts for patient and doctor preferences through utility values.
• Effective cost analysis provides a superior alternative to cost-only models for diagnostic test assessment.